HSKA Shares Outstanding History
Below is a table of the HSKA shares outstanding history going back to 12/30/2010:

Date HSKA Shares Outstanding
12/30/20105.22M
3/17/20115.23M
5/4/20115.23M
8/4/20115.24M
11/11/20115.24M
2/27/20125.26M
5/10/20125.32M
8/13/20125.35M
11/12/20125.36M
3/13/20135.80M
5/14/20135.80M
8/13/20135.83M
11/13/20135.84M
3/28/20146.04M
5/13/20146.22M
8/4/20146.29M
11/7/20146.32M
3/24/20156.48M
5/13/20156.50M
8/6/20156.53M
11/13/20156.59M
3/14/20166.62M
5/9/20166.68M
8/5/20166.88M
11/3/20166.90M
3/2/20177.05M
5/3/20177.12M
8/2/20177.23M
11/2/20177.24M
3/8/20187.31M
5/8/20187.46M
8/7/20187.50M
11/6/20187.59M
3/6/20197.74M
5/7/20197.75M
8/6/20197.80M
11/5/20197.83M
2/27/20207.84M
5/7/20209.39M
8/6/20209.44M
11/4/20209.45M
2/25/20219.48M
5/4/202110.42M
8/2/202110.65M
11/2/202110.71M
2/24/202210.81M
5/5/202210.79M
8/4/202210.82M

Also see: HSKA Market Cap History
HSKA YTD Return
HSKA Historical Shares Outstanding:
+6.48% CAGR
HSKA Historical Shares Outstanding: +6.48% CAGR

Mouse over chart for data details
12/30/2010 ...8/4/2022
Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production. We show 48 historical shares outstanding datapoints in our coverage of HSKA's shares outstanding history.

Understanding the changing numbers of HSKA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like HSKA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching HSKA by allowing them to research HSKA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree HSKA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Heska (HSKA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

HSTO Shares Outstanding History
HTBX Shares Outstanding History
HTGM Shares Outstanding History
HUMA Shares Outstanding History
HYH Shares Outstanding History
HZNP Shares Outstanding History
IART Shares Outstanding History
IBRX Shares Outstanding History
ICAD Shares Outstanding History
ICCC Shares Outstanding History
More Healthcare companies »

 

HSKA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.